Physical Activity Following Pulmonary Rehabilitation in COPD

NCT03660644 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2020-02-20

No results posted yet for this study

Summary

The aim of this feasibility study is to identify the acceptability of an intervention designed to promote physical activity following pulmonary rehabilitation for individuals with Chronic Obstructive Pulmonary Disease (COPD). Participants in the intervention group will be provided with pedometers and step diaries and added to a WhatsApp group with other graduates of pulmonary rehabilitation for 52 weeks.

Conditions

  • COPD
  • Physical Activity

Interventions

BEHAVIORAL

WhatsApp, Pedometer and Step Diary

Participants will be provided with a daily step diary and added to a group chat on WhatsApp. The group chat will be populated by other members of pulmonary rehabilitation programme (cluster) and the WhatsApp group leader will encourage participants to keep active. Participants will be encouraged to record the number of steps walked in a paper diary at the end of each day (i.e. prior to bedtime). This diary will simply have three columns: day of the week; number of steps; comments (optional). The intervention will last 52 weeks.

Sponsors & Collaborators

  • National Health Service, United Kingdom

    collaborator OTHER_GOV
  • British Lung Foundation

    collaborator OTHER
  • University College, London

    collaborator OTHER
  • University of Oxford

    collaborator OTHER
  • University of Lincoln

    lead OTHER

Principal Investigators

  • Hayley Robinson, MSc · University of Lincoln

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-13
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03660644 on ClinicalTrials.gov